The recommendation paper will address the roles and responsibilities of the sponsor and investigator, electronic informed consent, IMP delivery, trial related procedures at home, data management and monitoring in a decentralized clinical trial setting. The intention of this recommendation paper is to facilitate the use of decentralized elements in clinical trials in the EU/EEA.
Read the pdf